Literature DB >> 26992059

Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients.

Louise Nielsen1,2, Florence Canouï-Poitrine3,4, Jean-Philippe Jais5,6, Djamal Dahmane1, Pablo Bartolucci7,8,9, Bouteina Bentaarit1, Justine Gellen-Dautremer7, Philippe Remy1,2, Tomek Kofman1,2, Marie Matignon1,2, Caroline Suberbielle10, Christian Jacquelinet11,12, Orianne Wagner-Ballon13,14, Dil Sahali1,2, Philippe Lang1,2, Thibaud Damy15,16, Frédéric Galactéros7,8,9, Philippe Grimbert1,2, Anoosha Habibi7,8,9, Vincent Audard1,2.   

Abstract

We performed a retrospective study to assess the changes in clinical, biological and heart echocardiographic parameters in 32 sickle cell disease (SCD) patients beginning haemodialysis. Acute SCD-related complications were similar at 6 months before and 6 months after the initiation of haemodialysis. Median haemoglobin level did not change significantly, but the need for blood transfusions increased (P < 0·001). The 5-year incidence of death was higher in SCD patients (P < 0·0001). The 5-year likelihood of receiving a renal graft was lower in SCD patients (P = 0·022). Our findings suggest that SCD patients have poorer survival and a lower likelihood of receiving a renal graft.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  dialysis; kidney; sickle cell disease; survival; vaso-occlusive crises

Mesh:

Substances:

Year:  2016        PMID: 26992059     DOI: 10.1111/bjh.14040

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice.

Authors:  Malgorzata Kasztan; Brandon M Fox; Jeffrey D Lebensburger; Kelly A Hyndman; Joshua S Speed; Jennifer S Pollock; David M Pollock
Journal:  Blood Adv       Date:  2019-05-14

2.  Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life.

Authors:  Rima S Zahr; Evadnie Rampersaud; Guolian Kang; Mitchell J Weiss; Gang Wu; Robert L Davis; Jane S Hankins; Jeremie H Estepp; Jeffrey Lebensburger
Journal:  Haematologica       Date:  2019-03-19       Impact factor: 9.941

3.  Severe anemia early in life as a risk factor for sickle-cell kidney disease.

Authors:  Inmaculada Aban; Sujatha Baddam; Lee M Hilliard; Thomas H Howard; Daniel I Feig; Jeffrey D Lebensburger
Journal:  Blood       Date:  2016-12-05       Impact factor: 22.113

4.  The morbidity and mortality of end stage renal disease in sickle cell disease.

Authors:  Maya Viner; Jifang Zhou; David Allison; Jin Han; Robert E Molokie; Shivi Jain; Michel Gowhari; Victor R Gordeuk; Gregory Calip; Santosh L Saraf
Journal:  Am J Hematol       Date:  2019-03-01       Impact factor: 10.047

Review 5.  Chronic organ failure in adult sickle cell disease.

Authors:  Elliott Vichinsky
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Optimal disease management and health monitoring in adults with sickle cell disease.

Authors:  Jo Howard; Swee Lay Thein
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

7.  End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Authors:  Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy
Journal:  Blood Adv       Date:  2019-12-10

8.  Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.

Authors:  Jeffrey D Lebensburger; Gary R Cutter; Thomas H Howard; Paul Muntner; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2017-04-05       Impact factor: 3.714

Review 9.  Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment.

Authors:  Essa Hariri; Anthony Mansour; Andrew El Alam; Yazan Daaboul; Serge Korjian; Sola Aoun Bahous
Journal:  Int Urol Nephrol       Date:  2018-01-30       Impact factor: 2.370

10.  Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.

Authors:  Jeffrey D Lebensburger; Inmaculada Aban; Brandi Pernell; Malgorzata Kasztan; Daniel I Feig; Lee M Hilliard; David J Askenazi
Journal:  Am J Hematol       Date:  2019-01-08       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.